Previous 10 | Next 10 |
home / stock / ctabf / ctabf news
Canntab and Medipharm Labs Enter Into a Wholesale Tablet Purchase Agreement Canada NewsWire TORONTO, June 2, 2020 TORONTO , June 2, 2020 /CNW/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the " Company " or " Canntab "), the leading innovat...
Canntab Appoints Joshi Laxminarayan as Chief Scientific Officer Canada NewsWire TORONTO, May 15, 2020 TORONTO , May 15, 2020 /CNW/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and...
Canntab to Present at the Canaccord Genuity 2020 Virtual Cannabis Conference Canada NewsWire TORONTO, May 11, 2020 TORONTO , May 11, 2020 /CNW/ - Canntab Therapeutics Limited ( CSE:PILL.CN )( OTCQB:CTABF ) ( FRA:TBF1.F ) (the "Company" or "Canntab"), the leading innovator...
Canntab Closes Final Tranche of Private Placement for Aggregate Proceeds of $3.7m Canada NewsWire TORONTO, March 16, 2020 TORONTO , March 16, 2020 /CNW/ - Canntab Therapeutics Limited ( CSE:PILL.CN )( OTCQB:CTABF ) ( FRA:TBF1.F ) (the " Company " or " Canntab "), the lead...
Canntab Announces Replacement of Advisor Warrants and Intention to Appoint Larry Latowsky as Director and Executive Chairman of the Board Canada NewsWire TORONTO, March 6, 2020 TORONTO , March 6, 2020 /CNW/ - Canntab Therapeutics Limited ( CSE:PILL.CN )( OTCQB:CTABF ...
Vancouver, British Columbia--(Newsfile Corp. - February 25, 2020) - Canntab Therapeutics (CSE: PILL) (OTCQX: CTABF) (FSE: TBF1), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application, has been granted a Cannabis Research Licence by Health Canada. T...
Canntab Awarded Health Canada Cannabis Research Licence Canada NewsWire TORONTO, Feb. 24, 2020 TORONTO , Feb. 24, 2020 /CNW/ - Canntab Therapeutics Limited ( CSE:PILL.CN )( OTCQB:CTABF ) ( FRA:TBF1.F ) (the " Company " or " Canntab "), the leading innovator in cannabinoid...
TORONTO , Feb. 6, 2020 /PRNewswire/ - Canntab Therapeutics Limited ( CSE:PILL.CN )( OTCQB:CTABF ) ( FRA:TBF1.F ) (the " Company " or " Canntab "), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application, is pleased to announce that it is launc...
The final step to obtain a licence to process Canntab's cannabis hard pill formulation, at its fully built out Markham, Ontario facility. Retains Larry Latowsky , former CEO of Katz Group Canada and its flagship holding Rexall, as an advisor in order to strengthen Canntab's commerci...
TORONTO, Ontario , Nov. 20, 2019 /PRNewswire/ -- Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application, today announced the signing o...
News, Short Squeeze, Breakout and More Instantly...
Canntab Therapeutics Ltd Company Name:
CTABF Stock Symbol:
OTCMKTS Market:
Canntab Therapeutics Ltd Website:
Toronto, Ontario--(Newsfile Corp. - September 18, 2023) - Canntab Therapeutics Limited (CSE: PILL) (OTC Pink: CTABF) (FSE: TBF1) (the " Corporation ") announces that the Ontario Securities Commission (the " OSC ") has rejected the Corporation's application for a management cease trade order (the ...
TORONTO, ON / ACCESSWIRE / November 22, 2022 / Canntab Therapeutics Limited (CSE:PILL)(OTCQB:CTABF)(FRA:TBF1) (the " Company " or " Canntab ") a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is providing an update on several matters impac...
CANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKET Canada NewsWire TORONTO , Aug. 22, 2022 /CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the " Company " or " Canntab ") a leading innovator in cannabi...